Exelixis
EXEL
#1768
Rank
HK$95.42 B
Marketcap
HK$379.64
Share price
-3.66%
Change (1 day)
12.86%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company